Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Shukra Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations
 BSE Code
 524632
ISIN Demat
INE551C01028
Book Value
10.1085326
Mar.Cap(Rs.Cr)
528.26
P/E
28.52
Face Value
10
Go
Your are on :   Markets   |  Company Profile   |  Board Of Directors
Chairman & Managing DirectorDakshesh Shah
Executive DirectorPayal Mehta
Independent DirectorBhoomiben Patel
Sarjeevan Singh
Sonal Deepalbhai Gandhi
Executive DirectorSanskruti Patel
Dhruvin Shah
Independent DirectorPinki Nirmal Sagar
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)